$ARNA Recent Headlines SP 500 back for another crack at

New Post Public Reply Private Reply Replies (0) Message Board

Mar 26, 2014 at 11:00 AM

$ARNA Recent Headlines

S&P 500 back for another crack at major support 12:21 p.m. Jan. 31, 2014 - Michael Ashbaugh
Arena shares surge as marketer doubles sales force for diet drug 12:41 p.m. Oct. 15, 2013 - Russ Britt
Obesity drug makers jockey for position as analysts praise Vivus 1:06 p.m. Oct. 3, 2013 - Russ Britt
Hedge funds are buying these stocks right now 2:46 p.m. July 23, 2013 - Insider Monkey
5 stocks insiders are buying 2:52 p.m. June 7, 2013 - Insider Monkey
6 gut checks before the stock market's opening bell 7:47 a.m. March 7, 2013 - Shawn Langlois
Stocks to watch Monday: Transocean, Stratasys 10:22 a.m. March 4, 2013 - Sue Chang
Arena Pharmaceuticals down 7.4% in premarket 10:11 a.m. Jan. 22, 2013 - Steve Gelsi
What 2012’s winners and losers say about 2013 7:00 a.m. Dec. 14, 2012 - Howard Gold
6 gut checks before the stock market's opening bell 7:50 a.m. Dec. 12, 2012 - Shawn Langlois
4 charts challenging resistance 8:06 a.m. Oct. 16, 2012 - The Trading Deck
Vivus sees EU regulators rejecting diet drug 1:16 p.m. Sept. 21, 2012 - MarketWatch.com
Vivus falls 11% on EU drug approval update 12:07 p.m. Sept. 21, 2012 - Val Brickates Kennedy
Arena rises as Vivus sees anti-obesity setback 8:49 a.m. Sept. 21, 2012 - Greg Morcroft
Vivus says Europe likely to reject obesity drug 8:33 a.m. Sept. 21, 2012 - MarketWatch.com
Orexigen soars 19% on analyst buy rating 1:46 p.m. Sept. 6, 2012 - Val Brickates Kennedy
Arena jumps 12% amid takeover speculation 2:55 p.m. Aug. 14, 2012 - Val Brickates Kennedy
Arena trips Nasdaq short-sale circuit breaker 4:01 p.m. Aug. 1, 2012 - Val Brickates Kennedy
Arena Pharma share drop trips short-sale limit 3:16 p.m. Aug. 1, 2012 - Laura Mandaro
Eisai gears up for launch of Arena's diet drug 10:32 a.m. July 30, 2012 - Val Brickates Kennedy

Direct To Consumer Television Advertising Marks The Tipping Point For Belviq Sales 9:34 a.m. March 24, 2014 - Seeking Alpha
March Madness: Final Four Investing Bracket 2014 6:36 p.m. March 20, 2014 - Seeking Alpha
Arena Down With Overall Market - Sales Data No Help 8:27 a.m. March 17, 2014 - Seeking Alpha
Interesting ARNA Put And Call Options For May 2nd 11:11 a.m. March 13, 2014 - TheStreet.com
Arena Sees Growth Continue With Belviq 4:01 p.m. March 7, 2014 - Seeking Alpha
Have Anti-Obesity Drug Companies Failed? 3:09 p.m. March 7, 2014 - Seeking Alpha
ARNA April 25th Options Begin Trading 11:09 a.m. March 6, 2014 - TheStreet.com
Biotech Stock Roundup: InterMune Grabs Headlines with Impressive Data - Analyst Blog 10:58 a.m. March 5, 2014 - Zacks.com
Is A Short Squeeze Ahead for Arena Pharmaceuticals (ARNA)? - Tale of the Tape 9:23 a.m. March 4, 2014 - Zacks.com
10-K: ARENA PHARMACEUTICALS INC 4:52 p.m. March 3, 2014 - Edgar Online - (EDG = 10Q, 10K)
Company news for March 03, 2014 - Corporate Summary 10:06 a.m. March 3, 2014 - Zacks.com
Future Sales Of Arena Pharmaceuticals' BELVIQ: Let's Make Some Informed, Quantitative Predictions Using Expected Value 8:01 a.m. March 3, 2014 - Seeking Alpha
Yellen Comments Help Lift Dow 1.4% on Week 2:03 a.m. March 1, 2014 - Barrons.com
Arena Prescription Sales Up: Stops Stock Slide 5:28 p.m. Feb. 28, 2014 - Seeking Alpha
Arena Posts Wider Loss, Misses Ests - Analyst Blog 12:20 p.m. Feb. 28, 2014 - Zacks.com
Benzinga's Top #PreMarket Losers 7:15 a.m. Feb. 28, 2014 - benzinga.com
Arena's Belviq Sales To Hit $150 Million In 2014? 12:10 a.m. Feb. 28, 2014 - Seeking Alpha
Arena Falls On Quarterly Results 7:42 p.m. Feb. 27, 2014 - Seeking Alpha
Arena Pharmaceuticals' CEO Discusses Q4 2013 Results - Earnings Call Transcript 7:25 p.m. Feb. 27, 2014 - Seeking Alpha
Arena -5.2% AH on Q4 miss, guidance 5:19 p.m. Feb. 27, 2014 - Seeking Alpha

Momentum Indicators for Health Care Equities -- Research on Arena Pharma, Hemispherx Biopharma, PDL BioPharma and Celgene 8:16 a.m. March 20, 2014 - PR Newswire - PRF
Financial Results Releases and Schedules, Clinical Study Results, Partnerships, and Senior-Level Appointments - Analyst Notes on Arena, Horizon Pharma, Enanta, Vanda, and PTC 4:30 p.m. March 5, 2014 - PR Newswire - PRF
Arena Pharmaceuticals Provides Corporate Update and Reports Fourth Quarter and Full Year 2013 Financial Results 5:22 p.m. Feb. 27, 2014 - PR Newswire - PRF
Arena Pharmaceuticals to Provide Corporate Update and Report Financial Results on Thursday, February 27 9:00 a.m. Feb. 20, 2014 - PR Newswire - PRF
Brazilian Pharmaceutical Market 2014-2024 11:03 a.m. Feb. 12, 2014 - PR Newswire - PRF
Arena Pharmaceuticals Announces Filing for Marketing Authorization of BELVIQ® (lorcaserin HCl) in Brazil 9:00 a.m. Feb. 12, 2014 - PR Newswire - PRF
Arena Pharmaceuticals to Present at Two Upcoming Investor Conferences 9:00 a.m. Feb. 5, 2014 - PR Newswire - PRF
Healthcare Companies Announce Drug Launches, Upcoming Conference Calls, and Financial Results Schedules - Research Report on Bristol-Myers Squibb, Teva, Jazz, AmerisourceBergen and Arena 9:00 a.m. Jan. 9, 2014 - PR Newswire
Arena Pharmaceuticals to Present at the 32nd Annual J.P. Morgan Healthcare Conference 9:00 a.m. Jan. 6, 2014 - PR Newswire
Collaborations, FDA Approvals, Appointments, Patents, and Stock Movements - Research Report on Aetna, United Therapeutics, Perrigo, Arena Pharmaceuticals, and Keryx Biopharmaceuticals 9:00 a.m. Dec. 31, 2013 - PR Newswire
Obesity Stock Plays Standing Out from the Crowd 11:04 a.m. Dec. 20, 2013 - ACCESSWIRE
Insiders Trend Analysis: Tiger Oil and Energy Inc, Groupon Inc, General Motors Company Arena Pharmaceuticals 11:47 a.m. Dec. 19, 2013 - ACCESSWIRE
Opening Buzzers: General Motors Company, Sunedison Inc, Nokia Corporation, Arena Pharmaceuticals 11:11 a.m. Dec. 17, 2013 - ACCESSWIRE
Stock Price Updates, FDA 510(k) Clearances, Conference Presentation and Resignations - Research Report on Gilead, Oculus Innovative Sciences, ARCA biopharma, Arena Pharma, and Tonix Pharma 9:00 a.m. Dec. 9, 2013 - PR Newswire
Bearish Stocks Analysis: Morgan Stanley, Microsoft Corporation, Arena Pharmaceuticals, Vale SA, JPMorgan Chase & Co 10:17 a.m. Dec. 6, 2013 - PR Newswire
Blue Chip Stock News: Ariad Pharmaceuticals, Citigroup Inc, Arena Pharmaceuticals, Market Vectors Gold Miners 10:45 a.m. Dec. 5, 2013 - ACCESSWIRE
Notable News Of The Day: BlackBerry Ltd, Arena Pharmaceuticals, Groupon Inc, Zynga Inc 10:56 a.m. Dec. 2, 2013 - ACCESSWIRE
Promising Partnerships, Stock Price Updates and Participation in Upcoming Healthcare Conferences - Research Report on Quest Diagnostics, Cigna, Arena, Theravance, and Volcano 9:00 a.m. Nov. 29, 2013 - PR Newswire
Arena Pharmaceuticals to Present at the 25th Annual Piper Jaffray Healthcare Conference 9:00 a.m. Nov. 27, 2013 - PR Newswire
Trend Analysis Scan: Synovus Financial, Arena Pharmaceuticals, Facebook Inc, J.C. Penney Company, Citigroup 9:49 a.m. Nov. 26, 2013 - PR Newswire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Advanta's Game-Changer: Acquiring Misr Hytech to Expand in Africa

Advanta's Strategic Move into Africa Alright, let's cut to the chase. Advanta is making a big splash with its acquisition of Misr Hytech, a move that's going to shake things up in Africa's agricultural sector. This isn't just another merger to gloss over with your morning coffee. We're talking about a deal that's supposed to wrap up by January 31, 2027, bringing together...

Breakthrough T1D Pushes Global T1D Awareness Forward

Shining a Light on T1D with Global Efforts In a world where a change in lifestyle can happen at the drop of a hat, Breakthrough T1D is making waves by expanding their global "See T1D" campaign in honor of World Diabetes Day. This isn't your run-of-the-mill awareness push—this is about propelling an understanding of what life truly entails for those living with type 1...

AppLovin Legal Woes: A Deep Dive into Investor Claims

AppLovin Faces Legal Heat and Market Scrutiny Bitter truth has a way of crashing like a wave, and AppLovin (NASDAQ: APP) is feeling the brunt of it. Now knee-deep in a securities class action, the firm’s been accused of selling fairy tales about its AI capabilities, leaving investors clutching at substantial losses. If you’ve been banking on their promises between...

EFICYENT Ventures to Connect at Singapore FinTech Fest

Why the Singapore FinTech Festival Matters The world's hardly a stranger to hype, but the Singapore FinTech Festival carries some real weight. From November 18 to 20, 2026, this gig isn't just industry chatter—it's a high-stakes convergence of policymakers, financial institutions, fintech innovators like EFICYENT, and the money folk looking to mold the future of...

Lilly's Obesity Breakthroughs: A Step Beyond the Scale

Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...

BETR's Slide: Investors Face Big Losses, Leadership Shift

BETR Investors Left in the Lurch It's a real trainwreck, folks. Better Home & Finance Holding Company, trading under NASDAQ:BETR, is in the spotlight for all the wrong reasons. The company expanded the class period for its investor lawsuit to include even more dates between March and August 2026, reflecting a torturous ride for shareholders. Their stock cratered by a...

Uber Data Breach: Class Action Investigation Begins

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Webull Faces Class Action: Key Details for Investors

What's Really Going on With Webull? When you hear there's a class-action lawsuit brewing, you know something's gone real sideways. Webull Corporation (NASDAQ: BULL) finds itself neck-deep in a securities fraud class action alleging some dicey dealings with China. If you've got skin in the game—and if you bought Webull stock between April 26, 2025, and October 6,...

PASCAL's Holiday Gift Edit: Timeless Watches Shine

Fresh Sparkle for the Holidays Well, here we are again, staring down the barrel of another holiday season. And what do you know, PASCAL is out with its 2026 Holiday Gift Edit, like clockwork. This is the kind of stuff they’re good at—capturing a moment, slapping some color on it, and calling it a game-changer. Launching on November 14, this edit nods to their Timeless...

SmallRig Boosts Art-Driven Innovation in AI Era

The Interplay of Art and AI In a world where the lines between man and machine blur faster than ever, creators like SmallRig are boldly asking: what role should authenticity play when AI takes the stage? The Shenzhen International Art Museum and SmallRig stood shoulder to shoulder, tackling this head-scrambling question with a global gathering of art and tech giants. It's...